Press Releases Detail:
Avitar Sponsored The American Association Of Medical Review Officers Drug Testing Symposium
December 07, 2000
CANTON, MA, December 7, 2000 – Avitar, Inc. (AMEX: AVR) announced today that it sponsored and presented at the American Association of Medical Review Officers (AAMRO) program, "Drug Testing Symposium – 2001: Mapping the New Frontier," held in Las Vegas, Nevada, December 1-3, 2000. This three-day seminar provided information on the latest technologies, policies and procedures for drugs-of-abuse testing methods using oral fluid and hair. Topics discussed included workplace drug testing, point-of-collection testing, and approaches to reviewing specimen validity.
"As the sole manufacturer of both a point-of-collection oral fluid-based drugs-of-abuse test and hair-based test, we were delighted to sponsor an AAMRO symposium because of the organization’s role in establishing national standards of competency for Medical Review Officers. The symposium was attended by thought leaders and advocates of workplace drugs-of-abuse testing who learned first-hand of the advantages of administering on-site oral fluid-based drug tests," said Peter Phildius Avitar’s Chairman and Chief Executive Officer.
"At the conference, we were very encouraged by the overwhelming interest in our ORALscreen™ oral fluid point-of-collection test. During presentations on urine specimen validity, there was significant discussion regarding the challenge of the ever-increasing trend towards more sophisticated methods of test adulteration," said Matthew Andrie, Avitar’s Marketing Manager. "ORALscreen provides the MRO with a solution that defends against the failure to gather accurate test results due to the potential use of adulterants, especially in cases where substitute urine samples could be introduced in the collection process," he added.
The American Association of Medical Review Officers is a nonprofit medical board, which establishes national standards and certification for medical practitioners in the field of drug and alcohol testing. A Medical Review Officer (MRO) is a certified physician who serves as a drug testing facilitator and consultant who interprets drug test results in light of regulations, policy, and the donor’s medical history. All federally mandated drug and alcohol testing and some state laws require an MRO. AAMRO-certified MROs, MROs working towards recertification, drug testing administrators, MRO assistants, toxicologists and program administrators involved in school and workplace drug and alcohol testing programs, attended this seminar.
ABOUT AVITAR INC.
Avitar, Inc. (AMEX:AVR) headquartered in Canton, Massachusetts, develops, manufactures and markets innovative medical devices based on core technologies in oral fluid diagnostics and customized polyurethane applications. The Company markets a unique portfolio of substance abuse testing products and services that include ORALscreenTM, the world’s first rapid point-of-contact oral fluid test for drugs of abuse, ORALadvantageTM, the first comprehensive substance abuse program featuring its oral fluid-based products, HAIRscreenTM, a laboratory-based test for long term drug abuse using hair, and several other specialized tests for drugs of abuse. ORALscreen is a cost-effective drugs-of-abuse test with potential net cost savings of more than $100.00 per sample tested. Additional products include an oral fluid collection system for DNA testing as well as a proprietary line of polyurethane-based high tech medical devices.
For more information, see Avitar’s website at avitarinc.com.
This release forward looking statements that are subject to risks and uncertainties, including the development and marketing of new applications and other risks that are detailed from time to time in the Company’s filings with the Securities and Exchange Commission.